| GTO ID | GTC1372 |
| Trial ID | NCT01278914 |
| Disease | Prostate Cancer |
| Therapy | mRNA vaccine |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Phase I/II Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer |
| Year | 2002 |
| Country | Norway |
| Company sponsor | Oslo University Hospital |
| Other ID(s) | DC Prostate |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||